Market Analysis

Our chart of the month for September examines five focused companies growing at many multiples of their respective markets....

We estimate orthopedic sales were essentially flat against the prior year as the market faced difficult comparisons and macro headwinds....

Executives from some of the largest orthopedic companies gathered at OMTEC to discuss the operating environment and trends....

Knee replacement, hip replacement and spine have been the most susceptible to disruption from procedure cancelations during the pandemic....

We estimate orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges...

Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022....

Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies....

The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes....

Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will...

As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A as well as...